There's a New York Times article on a new kind (works on glutamate receptors) of drug for use with patients who have schizophrenia. It has only undergone preliminary tests so far. It may help in treating cognitive effects:
http://www.nytimes.com/2008/02/24/business/24drug.html
__________________
Now if thou would'st
When all have given him o'er
From death to life
Thou might'st him yet recover
-- Michael Drayton 1562 - 1631
|